ClinicalTrials.Veeva

Menu

Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

A

Assiut University

Status

Not yet enrolling

Conditions

Immune Thrombocytopenic Purpura
Thyroid Disorders

Treatments

Drug: Steroid and eltrombopage
Diagnostic Test: Laboratory test
Diagnostic Test: Search for thyroid disorders

Study type

Observational

Funder types

Other

Identifiers

NCT07059910
ITP and thyroid disorders

Details and patient eligibility

About

Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment

Full description

We investigate patients with ITP for screening of thyroid disorders and how to deal with it and effect of this on the ttt

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.

    • refractory ITP patients.

Exclusion criteria

  • patients with history of thyroidectomy

    • patients with history of drug induced ITP
    • patients with history of HCV, HBV and HIV infection.
    • Patients who refuse to contribute in this study.

Trial design

100 participants in 1 patient group

Patients known ITP
Description:
Patients known ITP either newly diagnosed, chronic, refractory Age 18 yrs and above Patients with thyrodiectomy will not be in our study
Treatment:
Diagnostic Test: Search for thyroid disorders
Diagnostic Test: Laboratory test
Drug: Steroid and eltrombopage

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems